🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Exciting #SABCS23 session in the Stars at Night Ballroom on enhancing #Immunotherapy for #TNBC! Discover insights from the #ATRACTIB study, which combined atezolizumab, paclitaxel & bevacizumab for 1L advanced TNBC.

Celebrating a successful conclusion to the year with the culmination #SABCS23! 🎉 Proud to have presented 5 studies, we continue to raise the bar each year and we can’t wait to see what the future holds for us. Thank you, San Antonio! Until next year, the journey continues! 👋

BRUTAL estas palabras del actor Anthony Hopkins: Deja ir a la gente que no está lista para amarte. Esto es lo más difícil que tendrás que hacer en tu vida y también será lo más importante. Deja de tener conversaciones difíciles con personas que no quieren cambiar. Deja de

Welcome everyone! Let's do this, we cannot wait to see what this #ThinkTankMeeting holds for us. Learning from each other, empowering the others and thinking out of the box, this is our mantra for the weekend.

Meet the chairs and some of the mentors of the event: Sarah Garrido, Mariana Chavez McGregor and Antonio Llombart-Cussac. Ready to stimulate and motivate all the mentees 💪🏻 #ThinkTankMeeting

Nadia Harbeck's talk on fundamental aspects for successful clinical trials generated great interest among participants. As a reference in oncology at a global level, Nadia brought valuable insights to the event, encouraging productive debates on the subject. #ThinkTankMeeting

Reassuring retrospective data on the safety of using assisted reproductive techniques in young BRCA-carriers with breast cancer presented by Matteo Lambertini, MD PhD. #ESMOBreast24 #ESMOAmbassadors ESMO - Eur. Oncology

Important subanalysis of SOFT/TEXT presented by Otto Metzger from Dana-Farber’s Breast Oncology Center. Particularly marked benefit with exemestane + OFS (vs tamoxifen or tam/OFS) in premenopausal patients with lobular histology. AI should be favored over tamoxifen in this population. #ESMOAmbassadors

At #ESMObreast24, we are honored to have Dr. Javier Cortes MD PhD , MEDSIR Senior Scientific Lead, participating as the chair in Gilead Sciences's industry satellite session titled "Experts Debate: Navigating the Complexities of Metastatic Breast Cancer Treatment."

MEDSIR and Debiopharm initiate clinical collaboration to explore potential synergy in advanced breast cancer treatment. Read the full press release: medsir.org/post/medsir-de… #WINBtrial #BreastCancer #IITs

very important news! Overall Survival seen in KN522!!!

#ASCO24 #bcsm here we go!

Starting day in ESMO Gyn.ESMO - Eur. Oncology MEDSIR

▶ EN DIRECTE | El pilar caminant de les festes de Sants: els borinots volen repetir el seu rècord #btvdirecte x.com/i/broadcasts/1…

El restaurant Terra d’Escudella fa ple l’última setmana de servei abans del tancament definitiu. 🗣️ “Volem que el nostre relleu tingui una línia continuista” beteve.cat/estils-de-vida…

Això és demencial.

La portada de Vanity Fair. Nótese el texto que la acompaña en un lado.

Our team is joining CLOC: Curso Latinoamericano de Oncología Clínica 2025 on March 7-8 in Barranquilla, Colombia 🇨🇴! Honored to attend with Dr. Javier Cortes MD PhD, MEDSIR Senior Scientific Lead, at the #breastcancer roundtable on Saturday, as well as the MEDSIR Start-Up Team attending. See you in Colombia! 🧡🔬

Nuestro equipo estará en el CLOC: Curso Latinoamericano de Oncología Clínica 2025 el 7 y 8 de marzo en Barranquilla, Colombia 🇨🇴! El Dr. Javier Cortes MD PhD, Líder Científico Senior de MEDSIR, participa en la mesa redonda sobre cáncer de mama el sábado! ¡Nos vemos en Colombia! 🧡🔬

Kicking off our first day in #Colombia 🇨🇴 with an inspiring visit to Dr. Sandra Ximena Franco and Dr. William_Mantilla at Fundación CTIC It was a pleasure to exchange insights and explore the future of oncology in the region. Thank you for the warm welcome! #Oncology #CancerResearch